Tomoyuki Ohe

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Chronic Myeloid Leukemia

Reactive Oxygen Species

Cancer Stem Cells

Top Venues

Chemical research in toxicology

Free radical research

Nature communications

International journal of molecular sciences

Keio University

University of Tokyo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Keio University Oct 01 2011

Japan

Associate Professor :: Faculty of Pharmacy

Taiho Pharmaceutical Sep 01 2009 - Sep 30 2011

Japan

Manager

Education History

University of Tokyo Apr 01 1988 - Mar 31 1997

Japan

PHD :: Faculty of Pharmacy

Publications

Kazuya Sumi, Kenji Tago, Yosuke Nakazawa, Kyoko Takahashi, Tomoyuki Ohe, Tadahiko Mashino, Megumi Funakoshi-Tago
Novel Mechanism by a Bis-Pyridinium Fullerene Derivative to Induce Apoptosis by Enhancing the MEK-ERK Pathway in a Reactive Oxygen Species-Independent Manner in BCR-ABL-Positive Chronic Myeloid Leukemia-Derived K562 Cells. International journal of molecular sciences 23 (2) (2022)
Chikako Shibazaki, Okishi Mashita, Kyoko Takahashi, Shigeo Nakamura, Tadahiko Mashino, Tomoyuki Ohe
Development of a Fluorescent-Labeled Trapping Reagent to Detect Reactive Acyl Glucuronides. Chemical research in toxicology 34 (11) (2021)
Shun Kageyama, Sigurdur Runar Gudmundsson, Yu-Shin Sou, Yoshinobu Ichimura, Naoki Tamura, Saiko Kazuno, Takashi Ueno, Yoshiki Miura, Daisuke Noshiro, Manabu Abe, Tsunehiro Mizushima, Nobuaki Miura, Shujiro Okuda, Hozumi Motohashi, Jin-A Lee, Kenji Sakimura, Tomoyuki Ohe, Nobuo N Noda, Satoshi Waguri, Eeva-Liisa Eskelinen, Masaaki Komatsu
p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response. Nature communications 12 (1) (2021)
Daisuke Yasuda, Tomoyuki Ohe, Kyoko Takahashi, Riyo Imamura, Hirotatsu Kojima, Takayoshi Okabe, Yoshinobu Ichimura, Masaaki Komatsu, Masayuki Yamamoto, Tetsuo Nagano, Tadahiko Mashino
Inhibitors of the protein-protein interaction between phosphorylated p62 and Keap1 attenuate chemoresistance in a human hepatocellular carcinoma cell line. Free radical research 54 (11-12) (2020)